Osaic Holdings
BCYC

Osaic Holdings’s Bicycle Therapeutics BCYC Stock Holding History

Osaic Holdings’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42 Hold
10
– – ﹤0.01% 7882
2026
Q1 		$46 Buy
+10
New +$57 ﹤0.01% 7683
2025
Q4 		– Sell
-18
Closed -$132 – 7866
2025
Q3 		$132 Hold
18
– – ﹤0.01% 7731
2025
Q2 		$125 Hold
18
– – ﹤0.01% 7542
2025
Q1 		$152 Sell
18
-742
-98% -$8.74K ﹤0.01% 7200
2024
Q4 		$10.6K Sell
760
-282
-27% -$6.04K ﹤0.01% 5762
2024
Q3 		$23.6K Sell
1,042
-217
-17% -$5.01K ﹤0.01% 5277
2024
Q2 		$25.5K Sell
1,259
-130
-9% -$2.94K ﹤0.01% 5171
2024
Q1 		$34.6K Sell
1,389
-594
-30% -$12.6K ﹤0.01% 4992
2023
Q4 		$35.9K Sell
1,983
-1,365
-41% -$22.6K ﹤0.01% 5115
2023
Q3 		$67.3K Buy
3,348
+1,028
+44% +$23.5K ﹤0.01% 4786
2023
Q2 		$59.2K Buy
2,320
+1,260
+119% +$29.3K ﹤0.01% 4823
2023
Q1 		$22.5K Sell
1,060
-250
-19% -$6.27K ﹤0.01% 5511
2022
Q4 		$38K Sell
1,310
-100
-7% -$2.68K ﹤0.01% 5127
2022
Q3 		$33K Buy
1,410
+460
+48% +$10.9K ﹤0.01% 5229
2022
Q2 		$16K Sell
950
-3,089
-76% -$65.1K ﹤0.01% 5755
2022
Q1 		$176K Sell
4,039
-295
-7% -$13.8K ﹤0.01% 4142
2021
Q4 		$264K Sell
4,334
-730
-14% -$40.3K ﹤0.01% 3695
2021
Q3 		$210K Sell
5,064
-13,132
-72% -$459K ﹤0.01% 3850
2021
Q2 		$552K Buy
18,196
+2,569
+16% +$77.6K ﹤0.01% 2922
2021
Q1 		$467K Sell
15,627
-6,485
-29% -$167K ﹤0.01% 2925
2020
Q4 		$397K Sell
22,112
-3,988
-15% -$77K ﹤0.01% 2857
2020
Q3 		$497K Sell
26,100
-8,000
-23% -$141K ﹤0.01% 2423
2020
Q2 		$537K Buy
34,100
+34,000
+34,000% +$523K ﹤0.01% 2285
2020
Q1 		$1K Buy
+100
New +$1.27K ﹤0.01% 5799

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Osaic Holdings's BCYC Position: Q2 2026 in Review

Osaic Holdings held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 10 shares worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #7882.

Osaic Holdings first reported a position in BCYC in Q1 2020 and has held it in 25 quarters since. The position peaked at $552K in Q2 2021. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Osaic Holdings held 10 shares of Bicycle Therapeutics worth $42 as of Q2 2026.
  • Osaic Holdings left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7882 holding.
  • Osaic Holdings first reported a position in Bicycle Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Bicycle Therapeutics position peaked at $552K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.